Filing Details
- Accession Number:
- 0001144204-13-059998
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-08 16:20:50
- Reporting Period:
- 2013-11-06
- Filing Date:
- 2013-11-08
- Accepted Time:
- 2013-11-08 16:20:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509418 | Ron P Ellis | 3000 Kent Ave Ste A1-100 West Lafayette IN 47906 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-06 | 3,000 | $12.00 | 26,154 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-07 | 1,089 | $1.91 | 27,243 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-07 | 1,911 | $1.91 | 29,154 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2013-11-07 | 1,089 | $0.00 | 1,089 | $1.91 |
| Common Stock | Stock option (right to buy) | Disposition | 2013-11-07 | 1,911 | $0.00 | 1,911 | $1.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-10 | No | 4 | M | Direct | |
| 24,267 | 2016-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 75,332 | Direct |
Footnotes
- The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- The reported securities are owned directly by P. Ron Ellis and Margaret Heard Ellis, JTWROS.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
